Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53

Cancer Research

Volumn 59, Issue 19, 1999, Pages 4848-4856

  Mathiasen, Ida Stenfeldt ^a   Lademann, Ulrik ^a   Jäättelä, Marja ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; CASPASE 3; COLECALCIFEROL DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN P53; SEOCALCITOL; STAUROSPORINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 0033214051     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Walters, M. R. Newly identified actions of the vitamin D endocrine system. Endocr. Rev., 13: 719-764, 1992.
2. Bouillon, R., Okamura, W. H., and Norman, A. W. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev., 16: 200-257, 1995.
3. 3: towards an endocrine therapy of brain tumors. J. Neurosci. Res., 37: 2178-2186, 1994.
4. Welsh, J. E. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem. Cell Biol., 72: 537-545, 1994.
5. Vandewalle, B., Wattez, N., and Lefebvre, J. Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT 29 cells: possible implication of intracellular calcium. Cancer Lett., 97: 99-106, 1995.
6. Vandewalle, B., Hornez, L., Wattez, N., Revillion, F., and Lefebvre, J. Vitamin-D3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis. Int. J. Cancer, 9: 806-811, 1995.
7. 3 and its analogues on induction of apoptosis in breast cancer cells. J. Steroid Biochem. Mol. Biol., 58: 395-401, 1996.
8. 3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol., 58: 367-376, 1996.
9. 3 analogue shows relation to promoter selectivity. J. Cell. Biochem., 66: 552-562, 1997.
10. Vieth, R. The mechanism of vitamin D toxicity. Bone Miner., 11: 267-272, 1990.
11. Mathiasen, I. S., Colston, K. W., and Binderup, L. EB1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J. Steroid Biochem. Mol. Biol., 46: 365-371, 1993.
12. 3 analogue EB1089. Endocrinology, 139: 2102-2110, 1998.
13. Ashkenazi, A., and Dixit, V. M. Death receptors: signaling and modulation. Science (Washington DC), 281: 1305-1308, 1998.
14. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.
15. Thornberry, N. A., and Lazebnik, Y. Caspases: enemies within. Science (Washington DC), 281: 1312-1316, 1998.
16. Jäättelä, M. Escaping cell death: survival proteins in cancer. Exp. Cell Res., 248: 30-43, 1999.
17. Adams, J. M., and Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science (Washington DC), 281: 1322-1326, 1998.
18. Xiang, J., Chao, D. T., and Korsmeyer, S. J. Bax-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA, 93: 14559-14563, 1996.
19. Adjei, P. N., Kaufmann, S. H., Leung, W-Y., Mao, F., and Gores, G. J. Selective induction of apoptosis in Hep 3B cells by topisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cystein protease P32. J. Clin. Invest., 98: 2588-2596, 1996.
20. Okuno, S., Shimizu, S., Ito, T., Nomura, M., Hamada, E., Tsujimoto, Y., and Matsuda, H. Bcl-2 prevents caspase-independent cell death. J. Biol. Chem., 273: 34272-34277, 1998.
21. Wright, S. C., Schellenberger, U., Wang, H., Kinder, D. H., Talhouk, J. W., and Larrick, J. W. Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J. Exp. Med., 186: 1107-1117, 1997.
22. Deiss, L. P., Galinka, H., Berissi, H., Cohen, O., and Kimchi, A. Catepsin D protease mediates programmed cell death induced by Interferon-γ, Fas/APO-1 and TNF-α. EMBO J., 15: 3861-3870, 1996.
23. Roberts, L. R., Kurosawa, H., Bronk, S. F., Fesmier, P. J., Agellon, L. B., Leung, W-Y., Mao, F., and Gores, G. J. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology, 113: 1714-1726, 1997.
24. Patel, T., Gores, G. J., and Kaufmann, S. H. The role of proteases during apoptosis. FASEB J., 10: 587-597, 1996.
25. James, S. Y., Mackay, A. G., and Colston, K. W. Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J. Mol. Endocrinol., 14: 391-394, 1995.
26. Guenette, R. S., Mooibroek, M., Wong, K., Wong, P., and Tenniswood, M. Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. Eur. J. Biochem., 226: 311-321, 1994.
27. 3-resistant MCF-7 cell line. Endocrinology, 137: 400-409, 1996.
28. Wu, G., Fan, R. S., Li, W., Ko, T. C., and Brattain, M. G. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells. Oncogene, 15: 1555-1563, 1997.
29. 3 and EB 1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res. Treat., 42: 31-41, 1997.
30. 3 potentiates the cytotoxic effect of TNF on human breast cancer cells. Mol. Cell. Endocrinol., 106: 157-162. 1994.
31. 2 in breast carcinoma cells. Oncogene, 10: 2297-2305, 1995.
32. Wissing, D., Mouritzen, H., Egeblad, M., Poirier, G. G., and Jäättelä, M. Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. USA, 94: 5073-5077, 1997.
33. Chinnaiyan, A. M., Tepper, C., Lou, L., O'Rourke, K., Seldin, M. A., Kischkel, F., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M. FADD/MORT1 is a common mediator of Fas/APO-1- and tumor necrosis factor-induced apoptosis. J. Biol. Chem., 271: 4961-4965, 1996.
34. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
35. Wissing, D., Mouritzen, H., and Jäättelä, M. TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20. Free Radical Biol. Med., 25: 57-65, 1999.
36. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
37. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
38. Enari, M., Hug, H., and Nagata, S. Involvement of an ICE-like protease in Fasmediated apoptosis. Nature (Lond.), 375: 78-81, 1995.
39. Shimizu, S., Eguchi, Y., Kamiike, W., Waguri, S., Uchiyama, Y., Matsuda, H., and Tsujimoto, Y. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene, 13: 21-29, 1996.
40. Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V. M., and Salvesen, G. S. Target protease specificity of the viral serpin CrmA: analysis of five caspases. J. Biol. Chem., 272: 7797-7800, 1997.
41. Nicholson, D. W. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotechnol., 14: 297-301, 1996.
42. Chinnaiyan, A., and Dixit, V. The cell-death machine. Curr. Biol., 6: 555-562, 1996.
43. Jänicke, R. U., Sprengart, M. L., Wati, M. R., and Porter, A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem., 273: 9357-9360, 1998.
44. Elstner, E., Linker-Israeli, M., Said, J., Umiel, T., de Vos, S., Shintaku, I. P., Heber, D., Binderup, L., Uskovic, M., and Koeffler, H. P. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res., 55: 2822-2830, 1995.
45. Bartek, J., Iggo, R., Gannon, J., and Lane, D. P. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene, 5: 893-899, 1990.
46. Narvez, C. J., and Welsh, J. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant. Endocrinology, 138: 4690-4698, 1997.
47. Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90: 405-413, 1997.
48. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
49. Friesen, C., Krammer, P. H., and Debatin, K. M. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med., 2: 574-577, 1996.
50. Yeh, W-C., de la Pompa, J. L., McCurrach, M. E., Shu, H-B., Elia, A. J., Shahinian, A., Ng, M., Wakeman, A., Khoo, W., Mitchell, K., El-Deiry, W. S., Lowe, S. W., Goeddel, D. V., and Mak, T. W. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science (Washington DC), 279: 1954-1958, 1998.
51. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
52. Evan, G., and Littlewood, T. A matter of life and cell death. Science (Washington DC), 281: 1317-1322, 1998.
53. Deveraux, Q. L., Takahashi, R., Salvesen, G. S., and Reed, J. C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature (Lond.), 388: 300-304, 1997.
54. Roy, N., Deveraux, Q. L., Takahashi, R., Salvesen, G. S., and Reed, J. C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J., 16: 6914-6925, 1997.
55. Jäättelä, M., Wissing, D., Kokholm, K., Kallunki, T., and Egeblad, M. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J., 17: 6124-6134, 1998.